Release Date: 29/06/22 19:20 Summary: Estimated Distribution Announcement Price Sensitive: Yes Download Document 226.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%